Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04365855 · ClinicalTrials.gov registry record · NA
The Olmsted NAFLD Epidemiology Study (TONES)
A NA study of Non-alcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 800
- Enrollment target
- 1
- Study location
NCT04365855: Recruiting NA study of Non-alcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis, sponsored by Mayo Clinic.
NCT04365855 is a NA study of Non-alcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 800 participants, above the 163-participant average among 57 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (391% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04365855, a NA study of Non-alcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are assessing the prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) in the population and assembling a well-characterized cohort of adults with NAFLD and NASH to validate models of NAFLD diagnosis and determine long-term outcomes.
Primary Outcome
Number of subjects with NAFLD and NASH determined by the MRE
Conditions Studied
Interventions
- OTHER Blood draw
- DIAGNOSTIC_TEST Magnetic Resonance Elastography
- PROCEDURE Liver biopsy
- PROCEDURE Fibro Scan
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2020-10-10 |
| Est. Completion | 2028-06 |
| Phase | NA |
What NCT04365855 shows while recruiting
NCT04365855 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, above the 163-participant average among 57 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (391% higher).
The record links to 2 conditions, with Non-alcoholic Fatty Liver Disease appearing as the primary indexed condition, and to 4 interventions - of which Blood draw is the first listed.
NCT04365855 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04365855 about?
NCT04365855 is a clinical study titled "The Olmsted NAFLD Epidemiology Study (TONES)". Researchers are assessing the prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) in the population and assembling a well-characterized cohort of adults with NAFLD and NASH to validate models of NAFLD diagnosis and determine long-term outcomes.
What is the current status of trial NCT04365855?
This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2020-10-10. Estimated completion is 2028-06.
What conditions does trial NCT04365855 study?
This clinical trial studies the following conditions: Non-alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis.
What interventions are being tested in trial NCT04365855?
The interventions under investigation include: Blood draw (OTHER), Magnetic Resonance Elastography (DIAGNOSTIC_TEST), Liver biopsy (PROCEDURE), Fibro Scan (PROCEDURE).
Who is sponsoring clinical trial NCT04365855?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04365855 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-alcoholic Fatty Liver Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04365855's enrollment target sits among peer trials
800 5th of 57 higher than 53 of 57 other Non-alcoholic Fatty Liver Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Non-alcoholic Fatty Liver Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intermittent Fasting for NAFLD in Adults
RECRUITING · NA
-
Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents
RECRUITING · NA
-
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
RECRUITING · NA
-
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
RECRUITING · NA
-
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
ACTIVE NOT RECRUITING · NA
-
Prevention of NAFLD in Hispanic Children
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI